Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 16.52 is 73% above its 3-year average of 9.55, near the high end of its 3-year range (0.00–22.91).
As of the fiscal period ended Tuesday, June 30, 2026. 6.54% above its 12-month average of 15.51.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.52.
QUICK RATIO (ACID-TEST)
16.52
QUICK RATIO (ACID-TEST) AVG TTM
15.51
QUICK RATIO (ACID-TEST) AVG 3Y
10.50
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.54%
CURRENT VS 3Y AVG
+57.31%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+393.21%
vs the sector median at left
MapLight Therapeutics, Inc.
Market Cap
$420.28M
Quick Ratio (Acid-Test)
16.52
TTM Avg
15.51
3Y Avg
10.50
5Y Avg
N/A
Market Cap
$420.34M
Quick Ratio (Acid-Test)
25.05
TTM Avg
8.87
3Y Avg
10.83
5Y Avg
12.06
Market Cap
$425.13M
Quick Ratio (Acid-Test)
3.28
TTM Avg
10.55
3Y Avg
42.24
5Y Avg
29.93
Market Cap
$425.52M
Quick Ratio (Acid-Test)
1.37
TTM Avg
1.43
3Y Avg
1.40
5Y Avg
1.53
Market Cap
$414.18M
Quick Ratio (Acid-Test)
6.40
TTM Avg
3.40
3Y Avg
4.68
5Y Avg
4.62
Market Cap
$412.28M
Quick Ratio (Acid-Test)
2.64
TTM Avg
6.72
3Y Avg
6.86
5Y Avg
10.10
Market Cap
$414.54M
Quick Ratio (Acid-Test)
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$429.88M
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.92
3Y Avg
4.56
5Y Avg
5.25
Market Cap
$410.18M
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.95
3Y Avg
1.91
5Y Avg
2.07
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $420.28M | 16.52 | 15.51 | 10.50 | N/A |
| Prothena Corporation plc (PRTA)vs › | $420.34M | 25.05 | 8.87 | 10.83 | 12.06 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $425.13M | 3.28 | 10.55 | 42.24 | 29.93 |
| Tilray Brands, Inc. (TLRY)vs › | $425.52M | 1.37 | 1.43 | 1.40 | 1.53 |
| Senseonics Holdings, Inc. (SENS)vs › | $414.18M | 6.40 | 3.40 | 4.68 | 4.62 |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.28M | 2.64 | 6.72 | 6.86 | 10.10 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $414.54M | 9.89 | 6.34 | 6.34 | 6.34 |
| NeoGenomics, Inc. (NEO)vs › | $429.88M | 3.35 | 2.92 | 4.56 | 5.25 |
| Myriad Genetics, Inc. (MYGN)vs › | $410.18M | 1.98 | 1.95 | 1.91 | 2.07 |
| Editas Medicine, Inc. (EDIT)vs › | $430.46M | 3.19 | 3.65 | 4.66 | 6.11 |
Quick Ratio
16.52
Excludes inventory
Current Ratio
16.52
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 16.52 |
| 2026-03-31 | 22.91 |
| 2025-12-31 | 20.01 |
| 2025-09-30 | 13.22 |
| 2025-06-30 | 4.89 |
| 2025-03-31 | 7.57 |
| 2024-12-31 | 7.20 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 12.72 |
| 2023-03-31 | 0.00 |
